Rinvoq’s recent Ad and its campaign Work
October 4, 2023 ⚊ 1 Min read ⚊ Views 89 ⚊ BLOG
The primary focus here revolves around Rinvoq’s recent achievement of gaining FDA approval for the treatment of ulcerative colitis (UC) in March. The advertisement’s catchy tagline reads, “Put it in check with Rinvoq,” and features a clever statement: “When UC became unpredictable, I found rapid symptom relief,” voiced from a character up in the rafters.
Rinvoq, a JAK inhibitor and one of two autoimmune therapies following AbbVie’s Humira, secured FDA approval for psoriatic arthritis in December of the previous year. Following this success, in January, it gained approval for treating moderate-to-severe atopic dermatitis, and just two months later, it added the UC label to its list of achievements. Its initial approval in 2019 was for the treatment of rheumatoid arthritis.
